MMJ International Holdings

MMJ BioPharma Cultivation finds itself at the center of a pivotal legal struggle with the Drug Enforcement Administration (DEA), accusing the agency of significant delays in processing its application to grow marijuana for pharmaceutical research. The company's lawsuit claims these delays have...

MMJ International Holdings (MMJ) and Global Cannabis Holdings (GCH) have closed a landmark partnership that could drastically change the U.S. and global cannabis industry landscape. According to information procured exclusively, the companies have laid out an ambitious plan for the first legal...

MMJ BioPharma Labs, MMJ BioPharma Cultivation and MMJ International Holdings in collaboration with a specialty pharmaceutical soft gelatin manufacturing company, has completed manufacturing of its THC, CBD capsule medicine formulated on compounds found in the cannabis plant. The company will...

MMJ BioPharma Cultivation, a DEA API Bulk Manufacturer applicant to grow marijuana received their advanced precision cultivation equipment. With this innovative cultivation technology MMJ BioPharma Cultivation will be able to reproduce quality strain specific cannabis to meet the DEA's...

Megan Sheehan of Sheehan & Associates, Attorneys representing MMJ International Holdings and MMJ BioPharma Cultivation etal, scheduled to execute on clinical trials in Huntington's disease and multiple sclerosis, filed a motion in federal court against the Drug Enforcement Administration,...

MMJ International Holdings, in collaboration with a specialty pharmaceutical solutions company, has been manufacturing gelatin capsule medicines based on compounds found in cannabis. The company will investigate these in clinical trials as potential treatments for multiple sclerosis (MS) and...